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Expression of the transcription factor AP-2a was
examined in cultured human epidermal cells. Levels
of AP-2a mRNA increased substantially after the
cultures reached con¯uence, similar to the expression
pattern of the differentiation markers involucrin and
keratinocyte transglutaminase. The level of AP-2a
protein in nuclear extracts declined markedly after
con¯uence, however, along with its ability to form
complexes with oligonucleotides containing the
AP-2 response element. In contrast, the levels of
AP-2a protein in cytoplasmic extracts increased
dramatically after con¯uence, but these extracts had
low DNA binding activity. Supershift experiments
with speci®c antisera detected only AP-2a and not
the b or g isoforms. Examination of its localization
by confocal microscopy revealed that AP-2a was
primarily in the nucleus of basal cells and largely
cytoplasmic in the most super®cial cells. Localization
was a dynamic phenomenon in that changing the
medium resulted in accumulation of this transcrip-
tion factor in the nucleus after several hours. Overall,
the data indicate that AP-2a transcriptional activity
is regulated in a differentiation-dependent manner in
cultured keratinocytes and that this occurs by reloca-
lization of the protein. Nuclear localization of the
AP-2a protein in basal cells permits its accessibility
to response elements in gene promoters, whereas
sequestration in the cytoplasm as the differentiation
program progresses curtails its transcriptional activ-
ity. This regulatory scheme may provide keratino-
cytes with the ability to restore AP-2 transcriptional
activity rapidly by redistribution to the nucleus after
receiving an appropriate growth signal, such as a
medium change. Key words: growth/involucrin/TGM1/
SCC-9/strati®cation. J Invest Dermatol 117:864±870, 2001
A
P-2a is a homodimeric 100 kDa transcription factor
with a core recognition element sequence of 5¢-
GCCNNNGGC-3¢ (Williams and Tjian, 1991). This
factor was ®rst puri®ed from HeLa cells on the basis of
its ability to bind to enhancer regions of SV40 and
human metallothionein IIA promoters and to stimulate transcrip-
tion from them in vitro (Mitchell et al, 1987). It is expressed in
neural crest cell lineages during mouse embryogenesis (Mitchell
et al, 1991) and, in view of the fatal defects that result in
homologous gene knockout mice (Schorle et al, 1996; Zhang et al,
1996), has a critical role during development. The expression of
AP-2a mRNA is stimulated upon differentiation of several cell
lines, including NT2 human teratocarcinoma and P19 mouse
embryonal carcinoma cells after treatment with retinoic acid
(Williams et al, 1988; Phillip et al, 1994), suggesting that this
transcription factor helps mediate differentiation events and even
certain retinoid actions during development. On the other hand,
AP-2a has also been reported in some cases to suppress
transcription. This action has been attributed to the speci®c
location of its response element, positioned so that protein binding
interferes either with assembly of the transcription machinery
(Gelman et al, 1995) or with binding by another, more critical
transcription factor at an overlapping site (Chen et al, 1997).
AP-2a is now known to be a family of proteins, resulting from
alternative splicing of transcripts from the same gene, that can form
heterodimers (Buettner et al, 1993; Meier et al, 1995; Ohtaka-
Maruyama et al, 1998). Five variants have been detected, two of
which appear to act as dominant negatives, and at least four of
which can be coexpressed in individual tissues. Moreover recent
work has revealed two other related genes encoding transcription
factors that bind to the same core response element (Moser et al,
1995; Bosher et al, 1996; Chazaud et al, 1996; Oulad-Abdelghani
et al, 1996). AP-2b and AP-2g are nearly identical to AP-2a in a
segment of 96 residues in the C-terminal half that are critical for
DNA binding and dimerization, and thus can form heterodimers,
but are substantially divergent in the activation domain (N-terminal
half), suggesting different interactions with the transcription
machinery. They have overlapping but distinct patterns of expres-
sion in tissues, and in knockout mice they display at least some
nonredundant function. Each is expressed in the strati®ed squamous
epithelia. Although AP-2 has been implicated in expression of
several epidermal keratins, a curious lack of effect of AP-2a
deletion on keratin expression in mouse epidermis (Talbot et al,
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1999) has been suggested to result from some overlap in function,
as indicated in certain other systems (Maconochie et al, 1999).
The intricate maturation process of epidermal keratinocytes
presumably occurs in concert with coordinated changes in
transcription factor expression or activity, elucidation of which
will be instrumental in understanding the normal program and its
perturbation in disease. Potential AP-2 response elements have
been noted by inspection in the promoters of a number of genes
encoding keratinocyte differentiation markers, and some show
functionality (Eckert et al, 1997). A recent report demonstrating the
role of a critical AP-2 site for conferring epidermis-speci®c
expression of the keratin 14 gene in transgenic mice (Sinha et al,
2000) has renewed interest in this transcription factor as an
important regulator of keratinocyte genes. Our effort is directed to
exploring the relation of AP-2 expression to keratinocyte pro-
gramming in culture. For this purpose, serially passaged cultures,
optimized for growth using 3T3 feeder layer support, are highly
appropriate inasmuch as they are well strati®ed and display key
features of terminal differentiation (Green, 1979). Our initial efforts
have revealed the unexpected ®nding that keratinoyte maturation is
accompanied by accumulation of AP-2 in the cytoplasm. Dynamic
intracellular localization of proteins is becoming recognized as an
important cellular mechanism for the regulation of activity. An
example is the cytoplasmic sequestration of transcription factors
NFkB and NFAT, precluding transcriptional activation until an
incoming signal results in nuclear relocalization. Our ®ndings
suggest that, like NFkB and NFAT, AP-2 transcriptional activity in
cultured keratinocytes is regulated in part by changes in its
distribution between nucleus and cytoplasm. Translocation be-
tween nucleus and cytoplasm has also been reported recently for
keratinocyte basonuclin (Iuchi et al, 2000).
MATERIALS AND METHODS
Cell culture Normal human epidermal keratinocytes (hEp) were
grown in the presence of lethally irradiated 3T3 feeder cells in a mixture
of Dulbecco±Vogt Eagle's and Ham's F-12 media (3:1) supplemented
with 5% fetal bovine serum, 0.4 mg per ml hydrocortisone, 10 ng per ml
epidermal growth factor (EGF), 10 ng per ml cholera toxin, 5 mg per ml
insulin, 5 mg per ml transferrin, 20 pM triiodothyronine, and 0.18 mM
adenine (Allen-Hoffmann and Rheinwald, 1984). Cells were inoculated
at a density of 7 3 104 per 10 cm dish and reached approximately 25%
con¯uence in 4 d, approximately 50% con¯uence in 5 d, and
approximately 100% con¯uence in 8 d. Cultures from passages 3 through
5 were used for experiments. SIK spontaneously immortalized human
epidermal cells (Rice et al, 1993) and SCC-9 malignant keratinocytes
(Rheinwald and Beckett, 1981) were grown in the same way except that
EGF was omitted from the medium for the latter. Swiss mouse 3T3
®broblasts (Todaro and Green, 1963) used for feeder layers were grown
in Dulbecco±Vogt Eagle's medium supplemented with 10% bovine
serum and examined for AP-2 localization without irradiation.
Northern blot analysis For isolation of total cellular RNA, hEp
cultures were washed twice with 10 ml of isotonic phosphate-buffered
saline (PBS) and lysed using Trizol reagent (Gibco BRL), a modi®cation
of the guanidinium thiocyanate/acid phenol solvent of Chomczynski and
Sacchi (1987). Samples of RNA (30 mg per lane) were fractionated in
1.5% denaturing agarose gels (Sambrook et al, 1989). The fractionated
RNAs were transferred to nitrocellulose membrane and ®xed by baking.
After transfer, the membrane was prehybridized at least 4 h at 42°C in a
solution containing 50% formamide, 5 3 sodium citrate/chloride buffer
(SSC), 5 3 Denhardt's solution, 50 mM sodium phosphate buffer
(pH 6.5), 0.1% sodium dodecyl sulfate (SDS), and 0.1 mg per ml
denatured sheared salmon sperm DNA. The membrane was then
hybridized sequentially with 32P-labeled cDNA probes speci®c for AP-2a,
human involucrin, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) overnight at 42°C. The hybridization solution contained 50%
formamide, 5 3 SSC, 1 3 Denhardt's solution, 20 mM sodium
phosphate buffer (pH 6.5), 0.1% SDS, and 0.1 mg per ml denatured
sheared salmon sperm DNA. After hybridization the membrane was
washed sequentially in two changes each of 2 3 SSC±0.1% SDS and 0.5
3 SSC±0.1% SDS, and then once in 0.1 3 SSC±0.1% SDS at 42°C for
20 min. Speci®c hybridization signals were visualized by autoradiography
and quantitated using a Molecular Dymanics SI phosphorimager. The
relative maximal levels of AP-2a and AP-2aB mRNA were estimated
by comparing exposure times, phosphorimage intensities, and relative
probe activities.
Two DNA probes for AP-2a were employed. The ®rst was an EcoRI/
NcoI fragment from a cDNA clone spanning nucleotides ±45 to +1223
common to the various alternatively spliced forms (cDNA clone was
kindly provided by Dr. Robert Tjian). The second, speci®c for AP-2aB
(nucleotides 873±1500), was prepared by polymerase chain reaction
(PCR) from human genomic DNA using the AP-2aB-speci®c primers
5¢-AGCGAATCCACTTGCTAACT-3¢ and 5¢-GAGGCATTTGGAG-
GGTCTAT-3¢ (Buettner et al, 1993). The involucrin probe was an 850
bp PstI fragment from the involucrin coding region in the genomic
subclone plambdaI-3H6B (Eckert and Green, 1986). The keratinocyte
transglutaminase (TGM1) probe was a 2.5 kb EcoRI fragment from the
cDNA clone hTG13 (Phillips et al, 1990). A 780 bp PstI/XbaI fragment
of the human GAPDH coding region was used to normalize for the
amount of RNA loaded in each lane. The probes were gel puri®ed and
labeled with [a-32P]dCTP to speci®c activities of 8±10 3 108 cpm per
mg using random primers (Ambion kit).
Preparation of nuclear and cytoplasmic extracts Preparations from
hEp were performed by a modi®cation (Chen et al, 1997) of the original
method of Schreiber et al (1989). After removal of residual 3T3 and
contaminating dermal ®broblasts, cells were harvested by trypsinization
and collected by centifugation in 15 ml tubes. Cell pellets from
individual cultures were rinsed twice in ice-cold PBS and resuspended in
0.5 ml of ice-cold hypotonic buffer [20 mM HEPES-HCl (pH 7.6),
1 mM ethylenediamine tetraacetic acid (EDTA), 10 mM NaCl, 1 mM
dithiothreitol, 0.5% Nonidet P-40] containing protease inhibitors
(0.2 mM phenylmethylsulfonyl ¯uoride and 1 mg per ml each of
leupeptin, aprotinin, pepstatin) and phosphatase inhibitors (5 mM sodium
pyrophosphate, 50 mM sodium vanadate). The cell suspension was
transferred to a 1.5 ml microfuge tube, incubated on ice for 15 min,
vortexed for 10 s, and centrifuged for 30 s at 16,000 3 g. The
supernatant (cytoplasmic extract) was transferred to a new tube. The
pelleted material was washed twice with 1 ml of ice-cold hypotonic
buffer and resuspended in 0.1 ml of extraction buffer (20 mM HEPES-
HCl pH 7.6, 1 mM EDTA, 430 mM NaCl, 1 mM dithiothreitol, 0.5%
Nonidet P-40) containing the protease and phosphatase inhibitors. After
20 min on ice with occasional shaking, the suspension was centrifuged
for 15 min at 16,000 3 g at 4°C, and the supernatant (nuclear extract)
was transferred to a new tube. After determination of protein
concentration (Bradford, 1976) using Coomassie G-250 (Bio-Rad),
aliquots of each extract were stored at ±80°C until use.
Immunoblot analysis Nuclear (12 mg) or cytoplasmic (40 mg)
extracts were fractionated on 10% SDS polyacrylamide (30:0.8) gels after
heating for 2 min at 100°C in the presence of SDS and 2-
mercaptoethanol. Proteins were then transferred to nitrocellulose
membranes (0.2 mm) in a buffer (pH 8.3) containing 25 mM Tris,
192 mM glycine, and 20% methanol at 15 V for 30 min at room
temperature utilizing a semidry electrotransfer cell (Bio-Rad).
Nonspeci®c binding was prevented by pretreating the membrane in 5%
nonfat milk in TBST buffer [20 mM Tris±HCl (pH 7.6), 0.15 M NaCl,
0.5% Tween-20] for 1 h at room temperature. The blots were then
incubated overnight at 4°C with AP-2a-speci®c mouse monoclonal
antibody 3B5 (hybridoma supernatant), which is directed against an
epitope between residues 165±200, just N-terminal to the DNA binding
domain (Turner et al, 1998). After three 15 min washes in TBST buffer,
the blots were incubated 1 h with peroxidase-conjugated goat antimouse
IgG (Amersham) diluted 1:5000 with TBST containing 5% nonfat milk.
Blots were then given three 15 min washes in TBST buffer and
developed using the ECL Plus system (Amersham).
Electrophoretic mobility shift assay Synthetic single strand DNA
olignucleotides were puri®ed in a denaturing 10% polyacrylamide gel
and annealed to their complementary oligonucleotides (Sambrook et al,
1989). Probes were end-labeled by ®lling in the recessed 3¢ ends with
[a-32P]dCTP using the Klenow fragment of Escherichia coli PolI.
Approximately 3 mg of nuclear or 8 mg of cytoplasmic extract were
preincubated on ice for 15 min with 0.5 mg of poly dI:dC in binding
buffer (20 mM HEPES±HCl pH 7.6, 1 mM EDTA, 2 mM
dithiothreitol, 120 mM NaCl, 10% glycerol). The labeled probe
(0.02 pmol, 2 3 105 cpm) was then added and the incubation was
continued for an additional 45 min on ice in a ®nal volume of 20 ml.
For competitive studies, the reaction mixtures were preincubated for
15 min on ice with various amounts of unlabeled competitor
oligonucleotide before addition of the labeled DNA. DNA±protein
complexes were resolved in a 6% nondenaturing polyacrylamide (29:1)
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gel in 0.25 3 TBE buffer (pH 8.3) containing 22.5 mM Tris, 22.5 mM
borate, and 0.5 mM EDTA. The gels were dried, exposed to ®lm, and
quanti®ed by phosphorimaging. For supershift analysis, reaction mixtures
were prepared as above without the radioactive DNA probe and
preincubated with 1 ml of speci®c antibody for 1 h on ice. The 32P-
labeled DNA probe was added and incubation on ice was continued for
an additional 45 min. DNA±protein±antibody complexes were then
electrophoresed and detected as above. Speci®c antibodies were mouse
monoclonal 5E4 (AP-2a) and rabbit polyclonal epitope-selected b94
(AP-2b) and g96 (AP-2g). Each of these antibodies is effective in
speci®cally recognizing only a single form of AP-2 (Turner et al, 1998;
T. Williams, unpublished).
Oligonucleotides used in this study, shown below, have a single G
overhang at the 5¢ end of one or both strands to allow labeling by ®lling
in with [32P]dCTP. In oligonucleotide (1) a 27-mer containing the AP-2
response element spans positions ±653 to ±628 in the human involucrin
promoter plus an added G overhang at each 5¢ end. The consensus
binding site is shown in bold, where underlined bases are those mutated
in the binding site in oligonucleotide (2). Oligonucleotide (3), a 24-mer
spanning positions ±132 to ±110 in the involucrin proximal promoter
(plus an added G overhang at the proximal end) contains an AP-1
response element shown in bold that is known to be active in
transcription (Welter et al, 1995). As an indication of speci®city, binding
of nuclear extract protein to (1) was prevented by a 25±50-fold excess of
the unlabeled oligonucleotide but was not affected by either (2) or (3)
(data not shown). The former oligonucleotide, with three point muta-
tions in strategic locations, did not form a protein complex when
radiolabeled and incubated with nuclear extract.
(1) 5¢-GAACTGCAGCCTCGGGCATAGAGGCT-3¢ 27-mer
3¢-TTGACGTCGGAGCCCGTATCTCCGAG-5¢
(2) 5¢-CTCTAACTGCAAACTCGTGCATAGAGGCTGGG-3¢ 33-mer
3¢-GAGATTGACGTTTGAGCACGTATCTCCGACCCG-5¢
(3) 5¢-GCCTGTGGTGAGTCAGGAAGGGG-3¢ 24-mer
3¢-GGACACCACTCAGTCCTTCCCCG-5¢
Immunocytochemistry Cultures were grown in small glass or plastic
culture chamber slides and ®xed at various times in PBS containing 2%
p-formaldehyde for 24 h. The slides were rinsed three times in PBS,
incubated in permeabilizing buffer [PBS with 10 mg per ml bovine
serum albumin (BSA) and 1% Triton X-100] for 1 h, incubated in
blocking solution (PBS with 10 mg per ml BSA and 0.5% Tween-20)
with two changes (15 min each), and ®nally incubated in 3B5
monoclonal anti-AP2a antibody or control ascites overnight at 4°C in a
moist chamber. The slides were then rinsed twice with blocking solution
(15 min each with agitation), and blocked in goat serum (1:50 in
blocking solution) for 30 min. Slides were then incubated in goat
antimouse Alexa Fluor 488 or goat antimouse Texas Red (Molecular
Probes, Eugene, OR) for 1 h, and rinsed in PBS with 0.5% Tween-20
for 1 h with agitation. Slides stained with Alexa Fluor 488 were
counterstained with the DNA-speci®c stain BO-PRO-3 iodide
(Molecular Probes) for 10 min and rinsed in PBS. Slides were mounted
in mounting medium (90% glycerol/10% PBS with 0.2% n-propyl
gallate) and examined using scanning laser confocal microscopy. A Bio-
Rad MRC 600 scanning laser confocal microscope was used for all
image collections (Cherr et al, 1999). Either a 203 or a 603 ultraviolet-
corrected objective lens was used, and Kalman averaging in the slow scan
mode was employed for most samples. Both the 488 nm and 568 nm
laser lines were employed to observe Alexa Fluor 488 and BoPro
¯uorescence simultaneously. Samples that had only Alexa 488 or BoPro
were observed to ensure there was no bleedthrough of signal between
the different channels. Control samples (control ascites or no primary
antibody) were observed ®rst for each experiment and black level and
gain were set based on whatever background ¯uorescence was present.
All subsequent images were collected at exactly the identical settings to
ensure direct comparability between treatments.
RESULTS
Time course of AP-2a, involucrin, and TGM1 mRNA
expression Levels of AP-2a mRNA were measured in hEp
cultures at various degrees of con¯uence. A probe that detected the
various alternatively spliced forms showed that the mRNA level
increased greatly starting at con¯uence and was maintained at
maximal values, 4±5-fold higher than in precon¯uent cells, for
approximately 2 wk (Fig 1). A probe speci®c for AP-2aB, a splice
variant serving as a negative regulator (Buettner et al, 1993), gave a
distinct pattern, low in log phase cultures, reaching a maximum
immediately after con¯uence, and then dropping sharply to half or
less of its maximal value. The maximal value of AP-2aB, around
day 9, was estimated as 10% of the maximal value of total AP-2a
detected with the general probe (judging by autoradiography and
phosphorimaging), but it was usually expressed at a much lower
level. Such a relatively low level may have prevented its detection
in a developmental study of AP-2a in mouse skin, where it was
found only in the dermis (Byrne et al, 1994).
During the transition from log phase growth to slower growth
after con¯uence, a number of differentiation markers are known to
increase in expression. As indicators of this process, mRNA levels
were measured for involucrin and TGM1, which are expressed
suprabasally in culture and in upper spinous cells in the epidermis
in vivo (Thacher and Rice, 1985). As is evident in Fig 1, expression
of both markers was very low during log phase growth. Levels of
TGM1 mRNA increased at least 10-fold and reached a maximum a
day after con¯uence, whereas levels of involucrin mRNA increased
at least 30-fold, reaching maximal values a week after con¯uence.
As shown in Fig 1 the time course of AP-2a mRNA expression
resembled that of the two differentiation markers.
Figure 1. Expression of AP-2a, involucrin, and TGM1 mRNA as
a function of time. Illustrated at the top are representative
phosphorimages of hybridization signals from the mRNA at the times
indicated. The bottom two panels show the relative amounts of mRNA
normalized to the GAPDH signal for each lane. Each value is the mean
of two independent experiments. The vertical arrow at day 8 shows
when the cultures reached con¯uence.
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Electrophoretic mobility shift analysis of AP-2 levels and
isoforms To complement the time course of AP-2 mRNA
expression, nuclear extracts from cultures at various stages of
growth were compared by mobility shift assay. As shown in
Fig 2(A), AP-2 response element binding activity was relatively
high in subcon¯uent cultures but dropped greatly after con¯uence
to 6%±20% of maximal values. By contrast, cytoplasmic extracts
prepared from the same cells contained low AP-2 DNA binding
activity at any stage of growth (Fig 3). In the experiment
illustrated, the degree of complex formation was 20-fold higher
using nuclear extracts from half-con¯uent cultures than from any of
the cytoplasmic extracts. Addition of cytoplasmic extract from
postcon¯uent cells did not reduce DNA binding activity of nuclear
extract from precon¯uent cells.
To identify the AP-2 isoforms in complexes observed in band
shift experiments, nuclear extracts were incubated with antibodies
speci®c for the a, b, or g family members. As seen in Fig 4, a
supershifted band was evident in the extracts of precon¯uent
through postcon¯uent cultures, but only using antibodies reacting
with AP-2a. No supershifts, regardless of cell growth state, were
observed using antibodies speci®c for AP-2b or AP-2g. AP-2b
mRNA has been detected in adult mouse skin, but the levels were
much lower than of AP-2a (Moser et al, 1995).
Distribution of AP-2a protein between nuclear and
cytoplasmic extracts The relative amounts of AP-2 protein
were examined by immunoblotting using a monoclonal antibody
speci®c for the a isoform. As shown in Fig 5, the relative amount
of this protein in nuclear extracts decreased markedly within 2 d
after con¯uence in a striking parallel to the DNA binding activity
evident in mobility shift experiments. By contrast, the protein in
cytoplasmic extracts increased markedly after con¯uence,
correlating well with the increasing mRNA level. No difference
was evident in mobilities of the major band of immunoreactive
protein in the two types of extract.
Localization of AP-2a by laser confocal microscopy As
shown in Fig 6(A), AP-2 immunoreactivity in rapidly growing
precon¯uent human epidermal cells, which exhibited little
strati®cation, was indeed concentrated in the cell nuclei. By
contrast, in cultures that recently reached con¯uence, a gradient of
AP-2 localization was evident. Basal cells (Fig 6B) appeared similar
to the precon¯uent cells, with prominent staining in the nucleus
and relatively little in the cytoplasm. The super®cial cells often
exhibited uniform staining, however, with little additional stain
visible in the nucleus (Fig 6C). In several experiments, linear
wounds were created in con¯uent cultures, and the cells migrating
into the wound were examined. The AP-2 staining pattern was
essentially identical to that observed in cells of the basal layer from
which the migrating cells were derived.
Figure 2. AP-2 DNA binding activity in nuclear extracts. Binding
activities were measured using nuclear extracts from cultures harvested
on the days indicated. (A) A representative phosphorimage of a resulting
gel; (B) relative AP-2 DNA binding activity in nuclear extracts
normalized to the binding in the day 4 extract. The asterisk (*) denotes a
lane without added extract. Values in the graph represent the means and
standard deviations from three independent experiments. The vertical
arrow at day 8 shows when the cultures reached con¯uence.
Figure 3. AP-2 DNA binding activity in cytoplasmic extracts.
Binding activities were measured using cytoplasmic extracts from cultures
harvested on the days indicated. The asterisk (*) denotes a lane without
added extract. NE denotes a lane in which nuclear extract from half-
con¯uent cultures was examined in parallel for comparison.
Figure 4. Identity of AP-2 isoforms
interacting with the AP-2 response element.
Protein complexes were analyzed using nuclear
extracts from cultures harvested on the indicated
days. Prior to the electrophoresis, incubations
were performed in the presence of antibodies
speci®c for the a, b, or g AP-2 isoforms as shown
above the lanes. The asterisk (*) denotes lanes
without added extract, and the minus sign (±)
denotes samples prepared without added
antiserum.
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AP-2 localization was in¯uenced markedly in the super®cial cells
of con¯uent cultures by changing the medium. This manipulation
induced an increase in nuclear staining evident after 3±8 h and
largely gone after a day. Figure 6 shows the striking contrast in
staining pattern obtained 3 d (panel C) vs 8 h (panel D) after a
medium change. Several other manipulations of physiologic
conditions had minor if any effect. For example, cells grown in
serum-free medium containing low levels of calcium (90 mM)
exhibited some cytoplasmic but stronger nuclear staining, a pattern
that was not much affected by raising the calcium level to 0.5 mM
for 3 d. Similarly, treating the cultures with 12-O-tetradecanoyl-
phorbol-13-acetate or forskolin for periods up to several hours did
not induce a clear change in distribution.
Cultures of the spontaneously immortalized human epidermal
keratinocyte line (SIK), which is minimally deviated from normal
in most properties (Rice et al, 1993), exhibited nearly the same AP2
localization patterns as normal human epidermal cells with respect
to growth, strati®cation, and medium change. The presence or
absence of EGF in the medium, to which the cell growth is quite
sensitive, had little if any effect. In contrast to the normal and SIK
cultures, which showed considerable cytoplasmic staining at
con¯uence, the malignant SCC-9 cells (which remain as a
monolayer) displayed a high concentration of staining in the
nucleus regardless of cell density (Fig 7A). The striking contrast
between the SCC-9 pattern and the extreme cytoplasmic staining
attainable in normal cells con¯uent for 3 wk is shown in Fig 7(B).
For further comparison, 3T3 cells were examined, as it was evident
in feeder layer cultures that their pattern was distinct. This
distribution, which also did not appear to be dependent upon cell
density, was characterized by clear cytoplasmic staining and a
striking perinuclear concentration of the immunoreactivity
(Fig 7C).
DISCUSSION
Be®tting a role of AP-2a in differentiation, stimulatory response
elements for this transcription factor have been described in
numerous gene promoters. In particular, its expression during
development in ectodermally derived lineages, including epidermis
(Mitchell et al, 1991), led to the recognition of a role for AP-2a in
the appearance in fetal mouse skin of keratins 5 and particularly 14
Figure 5. Distribution of AP-2a protein between nuclear and
cytoplasmic extracts. Nuclear or cytoplasmic extracts (12 mg or 40 mg
of protein, respectively) prepared from cultures harvested on the
indicated days were resolved by 10% SDS polyacrylamide gel
electrophoresis. The relative amounts of AP-2 protein were examined by
immunoblotting using a monoclonal antibody speci®c for the a isoform.
Figure 6. AP-2 localization in cultured hEp.
(A) Precon¯uent culture showing localization
primarily in nuclei. (B) Con¯uent culture showing
localization primarily in nuclei of basal cells. (C)
Con¯uent culture 3 d after medium change,
showing diffuse cytoplasmic labeling in the most
super®cial layer of cells. (D) Con¯uent culture 8 h
after medium change, showing marked nuclear
staining in the most super®cial layer of cells. (E)
Control precon¯uent culture processed in parallel
with (A) but lacking primary antibody. (F), (G),
(H) Same ®elds as (B), (C), and (D), respectively,
counterstained with nuclear-speci®c BoPro stain.
Figure 7. Contrast in localization between hEp, malignant
keratinocytes, and 3T3 cells. (A) SCC-9 squamous carcinoma cells,
showing predominant nuclear labeling. (B) Postcon¯uent hEp with
almost exclusively cytoplasmic labeling. (C) 3T3 ®broblasts, showing
labeling that is cytoplasmic and perinuclear.
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(Byrne et al, 1994), which have AP-2 response elements in their
promoters and are expressed primarily in basal keratinocytes. In
cotransfections, AP-2a stimulates the expression of reporters driven
by the keratin promoters in cell lines such as 3T3 and HepG2,
where these keratins are not normally seen, but it is clear that
AP-2a alone is insuf®cient for expression in vivo (Magnaldo et al,
1993; Byrne et al, 1994). On the other hand, a decrease in AP-2a
protein or DNA binding has been associated with later stages of
differentiation. For example, in the case of corneal epithelial cells,
the reduction in AP-2 response element binding observed after
con¯uence in nuclear extracts correlated with induction of keratin
3 (Chen et al, 1997). AP-2 has recently been found to regulate
expression of keratin 10 indirectly, by suppressing C/EBPa, a
stimulator of keratin 10 expression, in basal cells where AP-2
immunostaining was evident but not in super®cial cells where
staining was much reduced (Maytin et al, 1999). Our results provide
insight into one mechanism to achieve selective AP-2 activity in
basal cells. In these cells, we hypothesize that AP-2 protein is
translated and imported into the nucleus where it contributes to
transcription of basal cell keratins 5 and 14 and suppresses keratin 10
expression. As cells move super®cially, AP-2 activity is down-
regulated, contributing to loss of keratin 5 and keratin 14
expression and commencement of keratin 10 gene transcription.
We suggest that, at least under certain conditions, such as the
hyperproliferative state that occurs in cell culture, AP-2 down-
regulation is achieved by relocalization to the cytoplasmic
compartment. This may well be a reversible process so that,
when the cell receives the appropriate signal, AP-2 can be rapidly
re-imported into the nucleus and resume transcriptional activity.
Our ®nding that a medium change in culture stimulates nuclear
relocalization suggests that this mechanism may allow cells to
respond rapidly to a growth stimulus.
The mechanism regulating AP-2 localization remains to be
explored. Other examples of transcription factors exhibiting this
phenomenom may provide insight. One is the p65 subunit of
NFkB, which resides in the cytoplasm of resting cells in a complex
with the anchoring protein, IkB. When an incoming signal targets
IkB for proteolysis, NFkB is freed to enter the nucleus where it
exhibits transcriptional activity (reviewed in Mercurio and
Manning, 1999). Localization of another transcription factor,
NFAT, is regulated by the phosphorylation state of critical serine
residues, which results in masking of its nuclear localization signal
and exposing a nuclear export signal (Okamura et al, 2000).
Activation of calcineurin, a Ca2+ activated phosphatase, depho-
sphorylates these sites, resulting in rapid nuclear import.
Evidence has accumulated that the transactivating ability of the
AP-2 protein can be altered both by interaction with other proteins
and by post-translational modi®cation. AP-2a is capable of forming
complexes with a number of proteins including several transcrip-
tional coactivators (Kannan et al, 1999), the Myc and RB proteins
(Gaubatz et al, 1995; Batsche et al, 1998; Wu and Lee, 1998), and
SV40 T antigen (Mitchell et al, 1987). Binding to other protein or
post-translational modi®cation has also been invoked to explain the
observation that AP-2aB inhibits the DNA binding of AP2aA in
cell extracts but not when the latter is expressed by bacteria
(Buettner et al, 1993). Initial characterization of AP-2 transactivat-
ing activity in HeLa cells revealed stimulation by agents increasing
activity of protein kinases A or C (Imagawa et al, 1987) without
affecting AP-2 mRNA or protein levels (Luscher et al, 1989). A
dramatic increase in AP-2 response element binding, observed
upon treatment of hepatic stellate cells with a 5-lipoxygenase
inhibitor, has been attributed to post-translational modi®cation of
the protein (Chen et al, 1996). Our results are thus highly
compatible with the loss of DNA binding activity and cytoplasmic
relocalization of AP-2a protein in postcon¯uent keratinocyte
cultures being due to altered post-translational modi®cation or
binding to a protein not yet identi®ed. A plausible scenario would
involve sequestering AP-2 in an inactive state in the cytoplasm in
differentiating keratinocytes from which it is released by a
phosphorylation or dephosphorylation event that alters either the
factor itself or a binding protein. Although AP-2a is known to be
phosphorylated by protein kinase A in vitro and upon cAMP
treatment of adipocytes (Park and Kim, 1993; Garcia et al, 1999),
treatment of keratinocytes with activators of protein kinases A or C
did not alter its localization in this work.
Despite a progressive loss of nuclear AP-2 DNA binding activity
as cultured epidermal keratinocytes differentiate, our results show a
striking increase in AP-2a mRNA at con¯uence in keratinocyte
cultures, nearly in parallel with increases in mRNA for two
prominent differentiation markers. This emphasizes that high
expression levels of the mRNA are not necessarily accompanied
by high levels of transactivation at AP-2 response elements. In
addition, the overall AP-2 immuno¯uorescence intensity was
reduced in the super®cial cells, suggesting that the protein level also
decreased with differentiation. A similar observation has been made
upon transformation of PA-1 human teratocarcinoma cells by an
N-ras oncogene, which led to greater than a 6-fold increase in
AP-2a mRNA but also to a dramatic reduction in AP-2-
dependent transactivation (Kannan et al, 1994).
In some cells, increased AP-2 expression is associated with
increased growth, which may result from autocrine or paracrine
stimulation by factors it induces such as transforming growth factor
a (Berkowitz et al, 1997), insulin-like growth factor II (Zhang et al,
1998), insulin-like growth factor binding protein 5 (Duan and
Clemmons, 1995), ERBB-2 (Bosher et al, 1995), and perhaps
insulin-like growth factor I receptor (Turner et al, 1998). On the
other hand, AP-2 can also mediate reduction of growth by
stimulating p21WAF/CIP1. expression (Zeng et al, 1997) or complex
formation with Myc, impairing the latter's transactivating ability
(Gaubatz et al, 1995). Efforts have been made to link AP-2
expression to the neoplastic state and prognosis of human tumors,
but results of tumor surveys so far are mixed, with loss of expression
associated with invasiveness in breast cancer (Gee et al, 1999) and
malignant melanoma (Karjalainen et al, 1998) but with no
prognostic value in colorectal (Ropponen et al, 1999) or prostate
cancer (Lipponen et al, 2000).
AP2a has recently been detected cytoplasmically in certain
neoplasms, suggesting that intracellular localization needs to be
considered in judging prognosis. Indeed, in the case of ovarian
tumors, nuclear localization combined with low cytoplasmic
expression is associated with poorer survival (Anttila et al, 2000).
This observation is compatible with our ®ndings that hEp exhibit
cytoplasmic localization associated with keratinocyte differenti-
ation, whereas malignant SCC-9 cells display predominantly
nuclear localization at all times. Whether or not the neoplastic
behavior of tumor cells is a direct consequence of the localization of
AP-2, perturbation of its translocation from nucleus to cytoplasm is
of considerable interest. Keratinocytes promise to be a good model
system for elucidating the molecular basis of this phenomenon.
This work was supported by USPHS NIH grants AR27130, CA77833, P30
ES05707, and P42 ES04699.
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